Article: Linking genomics with proteomics to accelerate the search for drug targets
Several recent studies highlight the promise of combining genomics and proteomics to uncover new, robust drug targets.
List view / Grid view
Several recent studies highlight the promise of combining genomics and proteomics to uncover new, robust drug targets.
Researchers have used imaging mass cytometry to analyse the cellular landscape of diseased lung tissue in severe COVID-19, revealing insights into the disease.
The isolation of microbial DNA is a key prerequisite for determining the microbiome profile of each body habitat.
Researchers have shown that SARS-CoV-2 infects mouth cells, which could inform the development of treatments against the oral symptoms of COVID-19.
Listen along to learn more about drug development for schizophrenia from Dr Sri Gopal, Head of Psychiatry R&D for Janssen!
Professor David Merryman explains how his team targeted the serotonin 2B receptor in animal models to preserve cardiac function six weeks after a heart attack.
Simple Western™ is an automated capillary immunoassay that produces publication-ready data to meet the highest standards of data integrity and rigor.
Researchers have reviewed lung-on-a-chip technologies, finding they are useful for representing the various disease pathologies.
Magnetic separation with Dynabeads helps ensure that the isolated cells are not affected by passage through a dense column.
Why you should link genomics with proteomics to accelerate the search for effective drug targets.
Researchers are using a new method to isolate the complex between SARS-CoV-2 and the ACE2 receptor to keep it embedded in the cell membrane.
Professor Martin Michaelis and Dr Mark Wass explain why new SARS-CoV-2 variants are emerging around the world and how vaccines will have to adapt in response.
Working with RNA requires rigorous nuclease contamination controls in place. Stock up on Nuclease-Free tubes tips and buffers #Back2Lab
Using cryo-electron microscopy, researchers have imaged how the SARS-CoV-2 Spike protein changes with the D614G mutation to enable faster spread of infection.
Scientists have created the first model of early human embryos by reprogramming fibroblasts into a blastocyst-like structures.